World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
27862
World Ranking
2342
National Ranking
64

Roger Paredes publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roger Paredes sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 277 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Roger Paredes D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roger Paredes sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 66 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Roger Paredes is a researcher affiliated with the University of Vic - Central University of Catalonia in Spain. Their research focuses primarily on the field of Medicine, with significant contributions to Infectious Diseases, Virology, Molecular Biology, Epidemiology, and Neurology. The scientist's work spans a breadth of topics related to viral infections and their clinical implications.

They have a substantial publication record in the following main topics:

  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Gut microbiota and health

Some of the recent papers associated with their field include:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients, 2021, New England Journal of Medicine
  • Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study, 2022, The Lancet
  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19, 2020, New England Journal of Medicine
  • Mpox in people with advanced HIV infection: a global case series, 2023, The Lancet

Roger Paredes frequently collaborates with several co-authors in their research work. Notable frequent collaborators include:

  • Bonaventura Clotet
  • Marc Noguera-Julián
  • Lourdes Mateu
  • Mariona Parera
  • Nuria Izquierdo-Useros

The scientist publishes regularly in a variety of academic venues. Their more frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Journal of Antimicrobial Chemotherapy
  • Scientific Reports
  • Nature Communications

Roger Paredes has also contributed to book publications, notably through the European Organization for Nuclear Research, with a publication titled IN_CERT (UN-CERTAIN): ART, SCIENCE AND THOUGHT SINCE THE PANDEMIC in 2021.

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • 2011 update of the drug resistance mutations in HIV-1.

    Johnson Va;Calvez;Günthard Hf;Paredes R

  • 2017 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • 2014 Update of the drug resistance mutations in HIV-1.

    Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson

  • 2015 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

    Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve

  • 2019 update of the drug resistance mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Francesca Ceccherini-Silberstein;Charlotte Charpentier

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Gut Microbiota Linked to Sexual Preference and HIV Infection.

    Marc Noguera-Julian;Marc Noguera-Julian;Muntsa Rocafort;Yolanda Guillén;Javier Rivera

  • Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

    Alison J. Rodger;Rebecca Lodwick;Mauro Schechter;Steven Deeks

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.

    Jens D Lundgren;Birgit Grund;Christina E Barkauskas;Thomas L Holland

  • Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.

    Albert Tuldra;Carmina R. Fumaz;Ma José Ferrer;Ramon Bayes

  • Update of the drug resistance mutations in HIV-1: March 2013.

    Victoria A Johnson;Vincent Calvez;Huldrych F Gunthard;Roger Paredes

  • Balances: a New Perspective for Microbiome Analysis.

    J. Rivera-Pinto;J. J. Egozcue;V. Pawlowsky-Glahn;R. Paredes

  • Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe: Results From the EuroSIDA Study

    R Paredes;A Mocroft;O Kirk;A Lazzarin

  • Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.

    Athe M N Tsibris;Bette Tm Korber;Bette Tm Korber;Ramy Arnaout;Ramy Arnaout;Ramy Arnaout;Carsten Russ

  • The microbiome in respiratory medicine: current challenges and future perspectives

    Rosa Faner;Oriol Sibila;Alvar Agustí;Eric Bernasconi

  • Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.

    Lidia Ruiz;Javier Martinez-Picado;Joan Romeu;Roger Paredes

  • Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure

    Roger Paredes;Roger Paredes;Christina M. Lalama;Heather J. Ribaudo;Bruce R. Schackman

  • Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

    L Ruiz;E Negredo;P Domingo;R Paredes

  • Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.

    Eugenia Negredo;Luís Cruz;Roger Paredes;Lidia Ruiz

Frequent Co-Authors

Eugenia Negredo
Eugenia Negredo University of Vic - Central University of Catalonia
Alessandro Cozzi-Lepri
Alessandro Cozzi-Lepri University College London
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Javier Martinez-Picado
Javier Martinez-Picado University of Vic - Central University of Catalonia
Julià Blanco
Julià Blanco IrsiCaixa
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Lidia Ruiz
Lidia Ruiz IrsiCaixa
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens up a variety of career opportunities, many of which can be complemented with additional online qualifications. For those looking to expand their healthcare knowledge, exploring programs like the functional medicine np salary pathway can provide valuable insights into patient-centered care and holistic health approaches.

In addition to medical and scientific roles, careers in healthcare administration and support are growing. Obtaining a certified professional coder certification can enhance job prospects by enabling professionals to handle medical billing and coding efficiently, an essential part of the healthcare system.

For individuals with diverse backgrounds or challenging histories, there are inclusive programs designed to support success. Those researching online degrees for felons will find that microbiology-related fields can still be accessible with the right guidance and resources.

Lastly, the healthcare support field offers specialized roles like child life specialists. Understanding the child life specialist salary and career requirements can help microbiology graduates explore meaningful work supporting children and families during medical treatments.

Best Scientists Citing Roger Paredes

Trending Scientists

Recently Published Articles